These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Further investigation of the discriminative stimulus properties of MDA. Glennon RA, Young R. Pharmacol Biochem Behav; 1984 Apr; 20(4):501-5. PubMed ID: 6728867 [Abstract] [Full Text] [Related]
7. MDA: a psychoactive agent with dual stimulus effects. Glennon RA, Young R. Life Sci; 1984 Jan 23; 34(4):379-83. PubMed ID: 6694526 [Abstract] [Full Text] [Related]
8. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Glennon RA, Young R, Rosecrans JA. Eur J Pharmacol; 1983 Jul 22; 91(2-3):189-96. PubMed ID: 6617740 [Abstract] [Full Text] [Related]
9. Discriminative stimulus properties of DOM and several molecular modifications. Glennon RA, Young R, Rosecrans JA. Pharmacol Biochem Behav; 1982 Apr 22; 16(4):553-6. PubMed ID: 7071088 [Abstract] [Full Text] [Related]
10. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Glennon RA, Yousif M, Patrick G. Pharmacol Biochem Behav; 1988 Mar 22; 29(3):443-9. PubMed ID: 2896360 [Abstract] [Full Text] [Related]
11. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Baker LE, Taylor MM. Pharmacol Biochem Behav; 1997 Aug 22; 57(4):737-48. PubMed ID: 9259001 [Abstract] [Full Text] [Related]
12. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation. Glennon RA, Young R, Soine W. Gen Pharmacol; 1984 Aug 22; 15(4):361-2. PubMed ID: 6149169 [Abstract] [Full Text] [Related]
13. Mechanistic studies on DOM as a discriminative stimulus. Glennon RA, Hauck AE. Pharmacol Biochem Behav; 1985 Dec 22; 23(6):937-41. PubMed ID: 2934750 [Abstract] [Full Text] [Related]
14. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA. Rangisetty JB, Bondarev ML, Chang-Fong J, Young R, Glennon RA. Pharmacol Biochem Behav; 2001 Dec 22; 69(1-2):261-7. PubMed ID: 11420094 [Abstract] [Full Text] [Related]
15. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats. Li JX, Unzeitig A, Javors MA, Rice KC, Koek W, France CP. J Pharmacol Exp Ther; 2009 Nov 22; 331(2):671-9. PubMed ID: 19687292 [Abstract] [Full Text] [Related]
16. Role of serotonin in the discriminative stimulus properties of mescaline. Browne RG, Ho BT. Pharmacol Biochem Behav; 1975 Nov 22; 3(3):429-35. PubMed ID: 125425 [Abstract] [Full Text] [Related]
17. A comparison of the behavioral effects of DOM homologs. Glennon RA, Young R, Rosecrans JA. Pharmacol Biochem Behav; 1982 Apr 22; 16(4):557-9. PubMed ID: 7071089 [Abstract] [Full Text] [Related]
18. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline. Appel JB, Callahan PM. Eur J Pharmacol; 1989 Jan 02; 159(1):41-6. PubMed ID: 2707301 [Abstract] [Full Text] [Related]
19. Comparison of 2, 5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine for in vivo efflux of catecholamines from rat brain. Vrbanac JJ, Tilson HA, Moore KE, Rech RH. Pharmacol Biochem Behav; 1975 Jan 02; 3(1):57-64. PubMed ID: 1129355 [Abstract] [Full Text] [Related]
20. Drug discrimination studies with MDMA and amphetamine. Oberlender R, Nichols DE. Psychopharmacology (Berl); 1988 Jan 02; 95(1):71-6. PubMed ID: 2898791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]